12 Recruiting Studies Using Odronextamab
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Odronextamab
A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer Therapies
📍 Rush University Medical Center — Chicago, Illinois
B-cell Non-Hodgkin Lymphoma (B-NHL)
View Study & Checklist ➔A Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants With Previously Treated Aggressive B-cell Non-Hodgkin Lymphoma
📍 Hospital Aleman — Ciudad Autonoma de Buenos Aires, Buenos Aires
B-Cell Non-Hodgkin Lymphoma (B-NHL)
View Study & Checklist ➔A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular Lymphoma
📍 Boca Raton Clinical Research (BRCR) Global — Plantation, Florida
Follicular Lymphoma (FL)
View Study & Checklist ➔A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
📍 Mayo Clinic - Arizona — Scottsdale, Arizona
Diffuse Large B-cell Lymphoma (DLBCL)
View Study & Checklist ➔Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
📍 Mayo Clinic — Rochester, Minnesota
Lupus Nephritis (LN)
View Study & Checklist ➔A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
📍 City of Hope — Duarte, California
B-cell Non-Hodgkins Lymphoma (B-NHL)
View Study & Checklist ➔A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
📍 University of Arizona Cancer Center — Tucson, Arizona
Follicular Lymphoma (FL)
View Study & Checklist ➔Odronextamab in Low Tumor Volume Advanced FL
📍 Beth Israel Deaconess Medical Center — Boston, Massachusetts
Follicular Lymphoma
View Study & Checklist ➔Odronextamab for the Treatment of Relapsed and Refractory Diffuse Large B-cell Lymphoma Before and After Chimeric Antigen Receptor T-cell Therapy
📍 University of California Davis Comprehensive Cancer Center — Sacramento, California
Recurrent Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔Zanubrutinib in Combination With Odronextamab for the Treatment of Patients With Richter's Transformation
📍 City of Hope Medical Center — Duarte, California
Recurrent Transformed Chronic Lymphocytic Leukemia
View Study & Checklist ➔Odronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
Recurrent Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
📍 David Geffen School of Medicine at UCLA — Los Angeles, California
Relapsed/Refractory Follicular Lymphoma
View Study & Checklist ➔